NCT06127329View on ClinicalTrials.gov

Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2026

Conditions
Carcinoma, Non-Small Cell Lung
Interventions
PROCEDURE

BAI combine with DEB-BACE

"1. First treatment. Only infusion chemotherapy (THP + Platinum + Letitrexed), THP 20 \~30mg/m2, Nedaplatin 40mg/m2, Letitrexed 3mg/m2.~2. Second treatment. After infusionchemotherapy, EqualSpheres microsphere used for embolization: EqualSpheres microspheres (400 μm) 1tube was loaded and adsorbed THP (40 \~ 60mg/m2). End point of embolization: stagnation of blood flow in tumor feeding artery."

Trial Locations (1)

Unknown

Gang Wu, Zhengzhou

All Listed Sponsors
lead

Gang Wu

OTHER

NCT06127329 - Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC | Biotech Hunter | Biotech Hunter